Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank.

Abdallah MW, Larsen N, Mortensen EL, Atladóttir HÓ, Nørgaard-Pedersen B, Bonefeld-Jørgensen EC, Grove J, Hougaard DM.

J Neuroimmunol. 2012 Nov 15;252(1-2):75-82. doi: 10.1016/j.jneuroim.2012.07.013. Epub 2012 Aug 20.

PMID:
22917523
2.

Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study.

Abdallah MW, Larsen N, Grove J, Bonefeld-Jørgensen EC, Nørgaard-Pedersen B, Hougaard DM, Mortensen EL.

Cytokine. 2013 Feb;61(2):370-6. doi: 10.1016/j.cyto.2012.11.015. Epub 2012 Dec 23.

PMID:
23267761
3.

Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders.

Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM.

World J Biol Psychiatry. 2013 Sep;14(7):528-38. doi: 10.3109/15622975.2011.639803. Epub 2011 Dec 19.

PMID:
22175527
4.

Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort.

Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM.

Brain Behav Immun. 2012 Jan;26(1):170-6. doi: 10.1016/j.bbi.2011.09.003. Epub 2011 Sep 10.

PMID:
21933705
5.

Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study.

Abdallah MW, Pearce BD, Larsen N, Greaves-Lord K, Nørgaard-Pedersen B, Hougaard DM, Mortensen EL, Grove J.

Autism Res. 2012 Dec;5(6):428-33. doi: 10.1002/aur.1254. Epub 2012 Sep 24.

PMID:
23008271
6.

Neonatal levels of neurotrophic factors and risk of autism spectrum disorders.

Abdallah MW, Mortensen EL, Greaves-Lord K, Larsen N, Bonefeld-Jørgensen EC, Nørgaard-Pedersen B, Hougaard DM, Grove J.

Acta Psychiatr Scand. 2013 Jul;128(1):61-9. doi: 10.1111/acps.12020. Epub 2012 Oct 5.

PMID:
23039165
7.

Infections during pregnancy and after birth, and the risk of autism spectrum disorders: a register-based study utilizing a Danish historic birth cohort.

Abdallah MW, Hougaard DM, Nørgaard-Pedersen B, Grove J, Bonefeld-Jørgensen EC, Mortensen EL.

Turk Psikiyatri Derg. 2012 Winter;23(4):229-35.

8.

Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.

Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Croen LA.

J Neuroinflammation. 2014 Jun 20;11:113. doi: 10.1186/1742-2094-11-113.

9.

Potential cytokine biomarkers in autism spectrum disorders.

Rose D, Ashwood P.

Biomark Med. 2014;8(9):1171-81. doi: 10.2217/bmm.14.39. Review.

PMID:
25402586
10.

Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology.

Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, Hougaard DM.

Clin Chem. 2005 Oct;51(10):1854-66. Epub 2005 Aug 4.

12.

Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study.

Lauritsen MB, Pedersen CB, Mortensen PB.

J Child Psychol Psychiatry. 2005 Sep;46(9):963-71.

PMID:
16108999
13.

Prenatal and neonatal peripheral blood mercury levels and autism spectrum disorders.

Yau VM, Green PG, Alaimo CP, Yoshida CK, Lutsky M, Windham GC, Delorenze G, Kharrazi M, Grether JK, Croen LA.

Environ Res. 2014 Aug;133:294-303. doi: 10.1016/j.envres.2014.04.034. Epub 2014 Jun 28. Erratum in: Environ Res. 2014 Oct;134:454.

PMID:
24981828
14.

Risk of autism spectrum disorders in children born after assisted conception: a population-based follow-up study.

Hvidtjørn D, Grove J, Schendel D, Schieve LA, Sværke C, Ernst E, Thorsen P.

J Epidemiol Community Health. 2011 Jun;65(6):497-502. doi: 10.1136/jech.2009.093823. Epub 2010 Jun 27.

PMID:
20584728
15.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

16.

Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.

Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N.

PLoS One. 2011;6(5):e20470. doi: 10.1371/journal.pone.0020470. Epub 2011 May 27.

17.

Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study.

Rai D, Lewis G, Lundberg M, Araya R, Svensson A, Dalman C, Carpenter P, Magnusson C.

J Am Acad Child Adolesc Psychiatry. 2012 May;51(5):467-476.e6. doi: 10.1016/j.jaac.2012.02.012. Epub 2012 Mar 21.

PMID:
22525953
18.

Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study.

Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H.

J Neuroinflammation. 2008 Nov 21;5:52. doi: 10.1186/1742-2094-5-52.

19.

Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study.

Atladóttir HÓ, Henriksen TB, Schendel DE, Parner ET.

Pediatrics. 2012 Dec;130(6):e1447-54. doi: 10.1542/peds.2012-1107. Epub 2012 Nov 12.

20.

Supplemental Content

Support Center